
Cardiologa. Multi-imágenes en cardiología @imedCV. Miocardiopatias, cardiopatías familiares y 🫀🧬 @cardiogenSAC
Buenos Aires
Joined September 2020
- Tweets447
- Following294
- Followers438
- Likes2.8K
Rocío Blanco, MD 🇦🇷 retweeted
In hypertrophic cardiomyopathy genetics, “negative” has an expiry date. Updated panels uncover new answers, from ALPK3 and FHOD3 to deep intronic MYBPC3. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiomyopathy #cardiotwitter @ESC_Journals @escardio
Rocío Blanco, MD 🇦🇷 retweeted
Nuestro trabajo sobre el valor pronóstico de la FEVD por RMC en CA-TTR está online en @CurrProbsCardio
Un trabajo liderado por @Florcantora_ que comenzó con su presentación como abstract en @SAC_54 ✅ y completa el camino con una publicación internacional 🌎
¡Felicitaciones!
Rocío Blanco, MD 🇦🇷 retweeted
Our findings suggest a disruption of the PD-L1/PD-1 axis in lymphocytic acute myocarditis,
representing a potential target for future therapies.
@CardioOncology
@EricAdler17
jacc.org/doi/10.1016/j.jacad…
Rocío Blanco, MD 🇦🇷 retweeted
New publication in JACC: Case Reports: Recurrent cardiac myxomas in Carney complex.
This case highlights the importance of early recognition, multimodality imaging, and lifelong multidisciplinary follow-up in CNC.
@JACCJournals @imedCV @cardiohiba_resi @ManuChiodi @_RoBlanco
Rocío Blanco, MD 🇦🇷 retweeted
Optimizing Screening Intervals for At-Risk Relatives of Dilated Cardiomyopathy Carrying a TTNtv @FatkinLab @AChristensen112 @Dr_Pavia @ulvedreng @fernidom @ERNGUARDHeart @Ellenbroek ahajrnls.org/4xUupD2
Rocío Blanco, MD 🇦🇷 retweeted
🫀☕ Café con expertos | CUORE 26
Un espacio de encuentro para compartir experiencias, intercambiar conocimientos y conversar sobre casos clínicos junto a especialistas.
📅 13 de octubre
📍 Hilton BA | Puerto Madero
¡Los esperamos!
#CUORE26 #Cardiología #CaféExpertos #HIBA
Rocío Blanco, MD 🇦🇷 retweeted
Gene editing isn't just science fiction anymore - it's moving into cardiovascular care. See the official ACC scientific statement to see where the field stands and what it means for the future of heart disease treatment jacc.org/doi/10.1016/j.jacc.…
#JACC #cvGenetics #GeneEditing #CVD
Rocío Blanco, MD 🇦🇷 retweeted
🆕 SIMPOSIO MUERTE SÚBITA
🔗 Inscribite a través del link de nuestro perfil o us02web.zoom.us/meeting/regi…
¡Te esperamos!
#imedcv #muertesubita #argenetics #hiba
Rocío Blanco, MD 🇦🇷 retweeted
Should we rethink genetic testing in older #DCM patients?🧬
In this cohort of 686 patients:
📍median age 50, 62.1% male
📍1 in 5 patients over 55 years of age were
genotype-positive
📍30% of genotype-positive patients >55 years had high-risk genotypes
📍Similar risk of ventricular arrhythmias & end-stage HF vs younger patients
📚Read more in #EJHF @EJHFEiC :
doi.org/10.1093/ejhf/xuag055
#HeartFailure #Cardiomyopathy #Genetics
@escardio @MarcoMetra @dougcannie @ath_bakalakos @ESC_Journals
Rocío Blanco, MD 🇦🇷 retweeted
The last 10 years have truly revolutionized our understanding of HCM and brought with it tremendous developments in new medicines
Time to think beyond our historical simple assumptions
This study nicely shows the need to adapt and sub-phenotype
Asymptomatic HCM shouldn't only rely on symptoms. Evaluating MR/LA size/diastolic dysfunction, NTproBNP, and exercise induced PH allows one to truly phenotype this group further.
jacc.org/doi/10.1016/j.jacc.…
#CardioTwitter
Rocío Blanco, MD 🇦🇷 retweeted
🧬Precision medicine paradox: the more we stratify patients, more fragmented our datasets become
In #rarediseases, this means overfitting, weak external validation & limited reproducibility
Solution? Collaboration, shared standards & better biobanking 🌍🤝
thelancet.com/journals/landi…
Rocío Blanco, MD 🇦🇷 retweeted
🆕 Muy contento de compartir una nueva publicación de nuestro equipo 🙌
“The role of nutritional status, measured by serum albumin, as a prognostic factor in wild-type transthyretin amyloidosis”
Los invito a leer el trabajo completo ⬇️
tandfonline.com/eprint/M9J7V…
Rocío Blanco, MD 🇦🇷 retweeted
🧬 Genetic testing in Dilated Cardiomyopathy: are we using it right?
A new ESC consensus highlights a key shift:
genetics in DCM is no longer just about family screening—it’s now central to clinical decision-making.
🔍 Key messages
🧠 Not just monogenic anymore
DCM is increasingly seen as a continuum:
Rare variants (high impact)
common variants (polygenic background)
environmental triggers
➡️ Disease = interaction, not a single mutation
🧬 Who should be tested? → almost everyone
Genetic testing is recommended when results can impact:
✔️ diagnosis
✔️ prognosis
✔️ treatment (e.g. ICD decisions)
✔️ family screening
➡️ Even “acquired” DCM does NOT exclude genetics
📊 Yield is variable but meaningful
~8–36% overall
up to 55% in familial DCM
➡️ Still clinically impactful despite imperfect yield
⚠️ Gene panels: bigger ≠ better
Large panels increase VUS
Limited gain in actionable variants
➡️ Focus on validated disease genes is key
🔥 Genotype matters clinically
Some genes carry higher arrhythmic risk:
LMNA, FLNC, DSP, RBM20, PLN
➡️ Can influence ICD decision-making beyond EF
🧩 The real paradigm shift: interpretation
Genetic results must be read in context:
phenotype
environment (e.g. myocarditis, chemo, pregnancy)
penetrance
➡️ A variant alone is NOT the diagnosis
👨👩👧 Family impact is huge
Enables cascade screening
Can discharge gene-negative relatives
Opens reproductive options
💡 Take-home message
Genetic testing in DCM is no longer optional or “nice to have”—
it’s becoming a core part of precision cardiology.
👉 But its value depends entirely on how well we interpret it.
#Cardiology #DCM #Genetics #Cardiomyopathy #PrecisionMedicine #HeartFailure #ESC #MedEd 🧬🫀
doi.org/10.1093/eurheartj/eh…
Rocío Blanco, MD 🇦🇷 retweeted
Hypertrophic cardiomyopathy: changing the paradigm of exercise prescription and competitive sport participation academic.oup.com/eurheartj/a…
Rocío Blanco, MD 🇦🇷 retweeted
Ya está disponible un nuevo número de @revistarac 📖
Compartimos un interesante artículo liderado por @Florcantora_ acerca del valor pronóstico del SLG medido en #whycmr en pacientes con MCH seguidos en @imedCV 🫀
👇👇👇
rac.sac.org.ar/index.php/rac…
Rocío Blanco, MD 🇦🇷 retweeted
🧬Más del 30% de pacientes con #EnfermedadesRaras no llegan a conocer el diagnóstico genético de su enfermedad. Proyectos como #IMPaCT-Genómica han demostrado arrojar luz donde solo había sombras. Necesitamos
integrar la genómica en la práctica clínica.
lavozdegalicia.es/noticia/so…
Rocío Blanco, MD 🇦🇷 retweeted
🫀 Quimioterapia + mutación DSP + RMN con realce en anillo + CDI
👉 La QT como second hit en DSP
Esto te mostramos en este caso que publicamos en #JACCCaseReports @JACCJournals junto a @_RoBlanco @G1FERNANDEZ @BroggerNoel
jacc.org/doi/epdf/10.1016/j.…
Rocío Blanco, MD 🇦🇷 retweeted
Inauguramos temporada de ateneos en @cardiogenSAC " No todo es tan simple " ... explorando la arquitectura compleja de #HCM de la mano de @jpocardio @eduardo_oc12 @_RoBlanco
Rocío Blanco, MD 🇦🇷 retweeted
🥂The Seaport Criteria - a new histologic Standard to Diagnose Myocarditis - the Lake Louise criteria of histology to diagnose myocarditis
sciencedirect.com/science/ar…
Rocío Blanco, MD 🇦🇷 retweeted
Miocardiopatía por TTN: expandiendo la relevancia clínica más allá de la banda A #REC. revespcardiol.org/es-miocard…














































